Abstract
We describe a patient with a primary diffuse large B-cell lymphoma of the central nervous system who developed a localized testicular relapse after 8 years. Both tumours lacked HLA-DR expression, the relapse additionally lost HLA class I expression. Immunoglobulin heavy chain gene rearrangements were identical in both lymphomas with extensive and ongoing somatic hypermutations resulting in extensive idiotype modulation. We hypothesize that these immune sanctuaries initially provided a safe haven for the tumour cells. When the environment becomes more permissive for an anti-tumour response, the continuous idiotype modulation and progressive loss of HLA expression on the tumour cells facilitates further immune escape.Primary central nervous system lymphoma (PCNSL) and lymphoma of the testis are rare forms of diffuse large B cell lymphoma (DLBCL). Both lymphoma types are immune-privileged site-associated DLBCL (IP-DLBCL), are EBV negative (except for immune-compromised patients), and almost exclusively have an activated B cell-like (ABC) phenotype.1,2 Lymphomas are considered to develop and progress in a multistep manner due to accumulation of genetic aberrations. Where a lymphoma is subject to selective pressure of the immune system, such aberrations may give rise to an immune escape phenotype.3 A common aberration leading to immune escape of PCNSL and testicular DLBCL is loss of HLA expression.4,5,6 Another common feature of both lymphoma types is a high level of (often ongoing) somatic hypermutation (SHM) in the immunoglobulin heavy chain (IgH) genes.1,7,8
Although usually presenting with stage IE disease, patients with PCNSL or testicular DLBCL have a poor prognosis that has only recently improved upon introduction of novel chemotherapy strategies.9,10 Primary testicular DLBCL frequently relapse in the CNS up to 10 years after initial presentation.10,11 Relapse of PCNSL is almost always (90–95%) confined to the CNS. One patient has been reported with a relapse of PCNSL in the testis, accompanied by extensive systemic involvement,12 but no patients have been described with a relapse solely in the testis. We describe a unique patient having a CNS lymphoma with a relapse confined to the testis 8 years after diagnosis. The ongoing modulation of the idiotype, in addition to progressive loss of HLA class II and I proteins, might have provided an efficient tumour escape mechanism in these lymphomas.
References
- Booman M, Douwes J, Glas AM, de Jong D, Schuuring E, Kluin PM. Primary testicular diffuse large B cell lymphomas have activated B cell-like subtype characteristics. J Pathol. 2006; 210:163-71. PubMedhttps://doi.org/10.1002/path.2033Google Scholar
- Camilleri-Broet S, Criniere E, Broet P, Delwail V, Mokhtari K, Moreau A. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood. 2006; 107:190-6. PubMedhttps://doi.org/10.1182/blood-2005-03-1024Google Scholar
- Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 2002; 3:991-8. PubMedhttps://doi.org/10.1038/ni1102-991Google Scholar
- Booman M, Douwes J, Glas AM, Riemersma SA, Jordanova ES, Kok K. Mechanisms and effects of loss of HLA class II expression in immune privileged site-associated B-cell lymphoma. Clin Cancer Res. 2006; 12:2698-705. PubMedhttps://doi.org/10.1158/1078-0432.CCR-05-2617Google Scholar
- Riemersma SA, Jordanova ES, Schop RF, Philippo K, Looijenga LH, Schuuring E. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune- privileged sites. Blood. 2000; 96:3569-77. PubMedGoogle Scholar
- Riemersma SA, Oudejans JJ, Vonk MJ, Dreef EJ, Prins FA, Jansen PM. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis. J Pathol. 2005; 206:328-36. PubMedhttps://doi.org/10.1002/path.1783Google Scholar
- Montesinos-Rongen M, Kuppers R, Schluter D, Spieker T, van Roost D, Schaller C. Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am J Pathol. 1999; 155:2077-86. PubMedGoogle Scholar
- Thompsett AR, Ellison DW, Stevenson FK, Zhu D. V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood. 1999; 94:1738-46. PubMedGoogle Scholar
- Batchelor T, Loeffler JS. Primary CNS lymphoma. J Clin Oncol. 2006; 24:1281-8. PubMedhttps://doi.org/10.1200/JCO.2005.04.8819Google Scholar
- Zucca E, Conconi A, Mughal TI, Sarris AH, Seymour JF, Vitolo U. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol. 2003; 21:20-7. PubMedhttps://doi.org/10.1200/JCO.2003.11.141Google Scholar
- Fonseca R, Habermann TM, Colgan JP, O’Neill BP, White WL, Witzig TE. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer. 2000; 88:154-61. PubMedhttps://doi.org/10.1002/(SICI)1097-0142(20000101)88:1<154::AID-CNCR21>3.0.CO;2-TGoogle Scholar
- Harney J, Pope A, Short SC. Primary central nervous system lymphoma with testicular relapse. ClinOncol (R. Coll. Radiol.). 2004; 16:193-5. Google Scholar
- Giudicelli V, Chaume D, Lefranc MP. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 2004; 32:W435-40. PubMedhttps://doi.org/10.1093/nar/gkh412Google Scholar
- Chenna R, Sugawara H, Koike T, Lopez R, Gibson TJ, Higgins DG. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 2003; 31:3497-500. PubMedhttps://doi.org/10.1093/nar/gkg500Google Scholar
- Lossos IS, Tibshirani R, Narasimhan B, Levy R. The inference of antigen selection on Ig genes. J Immunol. 2000; 165:5122-6. PubMedhttps://doi.org/10.4049/jimmunol.165.9.5122Google Scholar
- Klein U, Goossens T, Fischer M, Kanzler H, Braeuniger A, Rajewski K. Somatic hypermutation in normal and transformed human B cells. Immunol Rev. 1998; 162:261-80. PubMedhttps://doi.org/10.1111/j.1600-065X.1998.tb01447.xGoogle Scholar
- Lossos IS, Okada CY, Tibshirani R, Warnke R, Vose JM, Greiner TC. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood. 2000; 95:1797-803. PubMedGoogle Scholar
- Aarts WM, Bende RJ, Bossenbroek JG, Pals ST, van Noesel CJM. Variable heavy-chain gene analysis of follicular lymphomas: subclone selection rather than clonal evolution over time. Blood. 2001; 98:238-40. PubMedhttps://doi.org/10.1182/blood.V98.1.238Google Scholar
- Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, Chiorazzi N. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol. 2000; 164:2782-9. PubMedhttps://doi.org/10.4049/jimmunol.164.5.2782Google Scholar
- Paterson G, Wilson G, Kennedy PG, Willison HJ. Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation. J Immunol. 1995; 155:3049-59. PubMedGoogle Scholar
- Bende RJ, Aarts WM, Riedl RG, de Jong D, Pals ST, van Noesel CJ. Among B cell non-Hodgkin’s lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J Exp Med. 2005; 201:1229-41. PubMedhttps://doi.org/10.1084/jem.20050068Google Scholar
- Carson MJ, Doose JM, Melchior B, Schmid CD, Pliox CC. CNS immune privilege: hiding in plain sight. Immunol Rev. 2006; 213:48-65. PubMedhttps://doi.org/10.1111/j.1600-065X.2006.00441.xGoogle Scholar
- Fijak M, Meinhardt A. The testis in immune privilege. Immunol Rev. 2006; 213:66-81. PubMedhttps://doi.org/10.1111/j.1600-065X.2006.00438.xGoogle Scholar